Literature DB >> 3521461

Molecular pharmacology of botulinum toxin and tetanus toxin.

L L Simpson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521461     DOI: 10.1146/annurev.pa.26.040186.002235

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  75 in total

1.  Exogenous mRNA encoding tetanus or botulinum neurotoxins expressed in Aplysia neurons.

Authors:  S Mochida; B Poulain; U Eisel; T Binz; H Kurazono; H Niemann; L Tauc
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain.

Authors:  M Nagahama; J Sakurai
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Structural analysis of botulinum neurotoxin types A and E in aqueous and nonpolar solvents by Fourier transform infrared, second derivative UV absorption, and circular dichroic spectroscopies.

Authors:  B R Singh; F M Wasacz; S Strand; R J Jakobsen; B R DasGupta
Journal:  J Protein Chem       Date:  1990-12

4.  Preliminary X-ray crystallographic study of the receptor-binding domain of the D/C mosaic neurotoxin from Clostridium botulinum.

Authors:  Nipawan Nuemket; Yoshikazu Tanaka; Kentaro Tsukamoto; Takao Tsuji; Keiji Nakamura; Shunji Kozaki; Min Yao; Isao Tanaka
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-30

5.  Multiple GTP-binding proteins from cholinergic synaptic vesicles.

Authors:  J K Ngsee; K Miller; B Wendland; R H Scheller
Journal:  J Neurosci       Date:  1990-01       Impact factor: 6.167

6.  High-level expression, purification, crystallization and preliminary X-ray crystallographic studies of the receptor-binding domain of botulinum neurotoxin serotype D.

Authors:  Yanfeng Zhang; Xiaoli Gao; Ling Qin; Garry W Buchko; Howard Robinson; Susan M Varnum
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-11-25

7.  Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.

Authors:  S Kozaki; A Miki; Y Kamata; J Ogasawara; G Sakaguchi
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

8.  Re-engineering the target specificity of Clostridial neurotoxins - a route to novel therapeutics.

Authors:  K A Foster; E J Adams; L Durose; C J Cruttwell; E Marks; C C Shone; J A Chaddock; C L Cox; C Heaton; J M Sutton; J Wayne; F C G Alexander; D F Rogers
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

9.  Tetanus toxin channel in phosphatidylserine planar bilayers: conductance states and pH dependence.

Authors:  G Rauch; F Gambale; M Montal
Journal:  Eur Biophys J       Date:  1990       Impact factor: 1.733

Review 10.  Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms.

Authors:  Catherine A Thomas; Yao-Chi Chuang; Antonella Giannantoni; Michael B Chancellor
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.